Back to Research Hub
AtriCure, Inc.
ATRC
$27.30+0.39 (+1.43%)
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
StreetsValue research for AtriCure, Inc. (ATRC)
Members get the full report for AtriCure, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.